Drug firms cut doctors' fees for drug talks
McCarthy, M.
Bmj 348: G2021
2014
ISSN/ISBN: 0959-8138 PMID: 24607478 Document Number: 673714
Document emailed within 1 workday
Related Documents
Munro, R. 2001: Drug firms 'waging war' on the developing world Nursing Times 97(8): 10Andersson, M.L.; Böttiger, Y.; Lindh, J.D.; Wettermark, B.; Eiermann, B. 2013: Impact of the drug-drug interaction database SFINX on prevalence of potentially serious drug-drug interactions in primary health care European Journal of Clinical Pharmacology 69(3): 565-571
Romano, M. 2001: Prescription for conflict. AMA accepts funding from drug firms for campaign Modern Healthcare 31(25): 14
Watson, R. 2010: European Commission targets drug firms over illegal patent protection Bmj 340: C268
Gatty, B. 1993: Whatever happened to user fees and the FDA's promise to expedite new drug approvals? Hospital Formulary 28(7): 656 655
Schmidt, K. 2005: Still tougher bandages for control of drug costs. Defending yourself against regress fees MMW Fortschritte der Medizin 147(39): 50-51
Nishikaze, O. 1975: Drug-drug interaction and drug-induced interference with clinical laboratory test procedures--chairman's introductory remarks Rinsho Byori. Japanese Journal of Clinical Pathology 23(2): 75
Chren, M.M.; Landefeld, C.S. 1991: Doctors, drug companies and gifts Rhode Island Medical Journal 74(12): 603-610
Hunziker, C. 1982: Doctors--the duped drug suppliers? Minnesota Medicine 65(7): 425
Coglin, W.S.; McDonald, H.T.; Keppich-Arnold, P. 1971: Doctors's fees Medical Journal of Australia 1(10): 556-557
Crane, M. 1994: Doctors keep the lid on fees Medical Economics 71(18): 110-2 115-7 123-6
Hunziker, C. 1984: Doctors--the duped drug suppliers. Part Ii Minnesota Medicine 67(1): 31
Yamey, G. 2001: Pen "amnesty" for doctors who shun drug companies Bmj 322(7278): 69
Charatan, F. 2001: Doctors say they are not influenced by drug companies' promotions Bmj 322(7294): 1081
Matsuda, T. 1993: Antithrombotic drug (thrombolytic drug, anticoagulant, antiplatelet drug) Nihon Rinsho. Japanese Journal of Clinical Medicine 51 Suppl: 179-185
Crowley, T.J. 1985: Doctors' drug abuse reduced during contingency-contracting treatment Alcohol and Drug Research 6(4): 299-307
Carter, W.J. 1979: Doctors' fees and average male wages Medical Journal of Australia 2(8): 428
Kohl, C.; Steinkellner, M. 2000: Prediction of pharmacokinetic drug/drug interactions from in vitro data: interactions of the nonsteroidal anti-inflammatory drug lornoxicam with oral anticoagulants Drug Metabolism and Disposition: the Biological Fate of Chemicals 28(2): 161-168
Gardner, N. 1999: The doc stops here. Arkansas Medical Foundation helps doctors end drug abuse Journal of the Arkansas Medical Society 96(7): 245-247
Rabinovich, S.A. 1976: Drug resistance of malaria parasites. 2. Clinical aspects, drug treatment and prevention of drug-resistant malaria Meditsinskaia Parazitologiia i Parazitarnye Bolezni 45(6): 731-737